BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21225694)

  • 21. TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.
    Gerritsma AM; Sutera D; Cantarini L; Cattalini M; Lachmann HJ; Minden K; Jansson AF; Touitou I; Bustaffa M; Antón J; Insalaco A; Moreno E; Sanchez-Manubens J; Ruperto N; Frenkel J; Gattorno M;
    Clin Exp Rheumatol; 2023 Oct; 41(10):1998-2007. PubMed ID: 37470237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics.
    Lainka E; Neudorf U; Lohse P; Timmann C; Stojanov S; Huss K; von Kries R; Niehues T
    Rheumatology (Oxford); 2009 Aug; 48(8):987-91. PubMed ID: 19541728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience.
    Vergara C; Borzutzky A; Gutierrez MA; Iacobelli S; Talesnik E; Martinez ME; Stange L; Basualdo J; Maluje V; Jimenez R; Wiener R; Tinoco J; Jarpa E; Aróstegui JI; Yagüe J; Alvarez-Lobos M
    Clin Rheumatol; 2012 May; 31(5):829-34. PubMed ID: 22281876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic variability in two patients with tumor necrosis factor receptor associated periodic fever syndrome emphasizes a rare manifestation: Immunoglobulin A nephropathy.
    Balci S; Kisla Ekinci RM; Melek E; Atmis B; Bisgin A; Yilmaz M
    Eur J Med Genet; 2020 Apr; 63(4):103780. PubMed ID: 31586650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-
    Gaggiano C; Vitale A; Obici L; Merlini G; Soriano A; Viapiana O; Cattalini M; Maggio MC; Lopalco G; Montin D; Jaber MA; Dagna L; Manna R; Insalaco A; Piga M; La Torre F; Berlengiero V; Gelardi V; Ciarcia L; Emmi G; Ruscitti P; Caso F; Cimaz R; Hernández-Rodríguez J; Parronchi P; Sicignano LL; Verrecchia E; Iannone F; Sota J; Grosso S; Salvarani C; Frediani B; Giacomelli R; Mencarelli MA; Renieri A; Rigante D; Cantarini L
    Mediators Inflamm; 2020; 2020():8562485. PubMed ID: 32831641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.
    Ravet N; Rouaghe S; Dodé C; Bienvenu J; Stirnemann J; Lévy P; Delpech M; Grateau G
    Ann Rheum Dis; 2006 Sep; 65(9):1158-62. PubMed ID: 16569687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
    Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
    Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Baldari CT; Laghi Pasini F; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(3):405-7. PubMed ID: 20497634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
    Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
    Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations.
    Granel B; Serratrice J; Dodé C; Grateau G; Disdier P; Weiller PJ
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S93-5. PubMed ID: 17949559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
    Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
    Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.
    Mulazzani E; Wagner D; Havla J; Schlüter M; Meinl I; Gerdes LA; Kümpfel T
    J Neuroinflammation; 2020 Jun; 17(1):196. PubMed ID: 32563262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.
    Gattorno M; Pelagatti MA; Meini A; Obici L; Barcellona R; Federici S; Buoncompagni A; Plebani A; Merlini G; Martini A
    Arthritis Rheum; 2008 May; 58(5):1516-20. PubMed ID: 18438813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1β blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review.
    Soylu A; Yıldız G; Torun Bayram M; Kavukçu S
    Rheumatol Int; 2021 Jan; 41(1):183-188. PubMed ID: 31324971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA.
    Dagan E; Gershoni-Baruch R; Khatib I; Mori A; Brik R
    Rheumatol Int; 2010 Mar; 30(5):633-6. PubMed ID: 19579027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family History in Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA) Syndrome.
    Manthiram K; Nesbitt E; Morgan T; Edwards KM
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27565549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.